Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

p73 and p63 protein stability: the way to regulate function?

Carine Maisse1, Piero Guerrieri, Gerry Melino

  • 1Department of Experimental Medicine, Biochemistry Laboratory, IDI-IRCCS, University of Rome Tor Vergata, Rome, Italy.

Biochemical Pharmacology
|October 14, 2003
PubMed
Summary

The p73 protein, a homologue of p53, plays a role in cancer. Its stability and degradation are influenced by interactions with other proteins, impacting cancer prognosis.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[ViRAE 2025: a landmark inaugural edition for virology at INRAE].

Virologie (Montrouge, France)·2026
Same author

Autochthonous dengue transmission in Europe: epidemiology, mechanisms, and modelling insights.

Biology direct·2026
Same author

When vitamins decide life or death.

Cell death and differentiation·2026
Same author

Extracellular serine availability regulates inflammatory skin phenotypes.

Biology direct·2026
Same author

A novel TAp63γ-Airn regulatory axis governs early myogenic gene networks.

Biology direct·2026
Same author

Methodological guidelines for P2X receptor assays and data interpretation.

Cell death & disease·2026

Area of Science:

  • Molecular Biology
  • Cancer Research
  • Cell Biology

Background:

  • The p53 homologue p73 is implicated in tumorigenesis, but its precise molecular mechanisms remain unclear.
  • p73 exists in two isoforms, TA-p73 (pro-apoptotic) and DeltaN-p73 (anti-apoptotic), with their relative expression linked to cancer prognosis.
  • p73 and p63 proteins can interact, highlighting the need to understand their stability and degradation pathways.

Purpose of the Study:

  • To elucidate the molecular mechanisms underlying p73's role in tumorigenesis.
  • To investigate the factors controlling the stability and degradation of p73 and p63 proteins and their isoforms.
  • To detail the interactions of p73/p63 with Mdm2, p300/CBP, and SUMO-1.

Main Methods:

  • Review of existing literature on p73 and p63 molecular biology.

Related Experiment Videos

  • Analysis of protein modification pathways (phosphorylation, acetylation).
  • Examination of proteasomal degradation mechanisms.

    • Main Results:

    • The dual nature of p73 isoforms (TA-p73 vs. DeltaN-p73) contributes to opposing cellular functions.
    • Protein stability of p73 and p63 is modulated by post-translational modifications.
    • Proteasomal degradation is a key mechanism regulating p73 and p63 levels.

    Conclusions:

    • Understanding p73 and p63 stability is crucial for comprehending their roles in cancer.
    • Interactions with Mdm2, p300/CBP, and SUMO-1 are critical regulators of p73/p63 protein homeostasis.
    • Further research into these regulatory mechanisms may reveal novel therapeutic targets for cancer treatment.